Media
Dive into the latest news, press releases and reports from the Abacus Medicine Group.
Abacus Medicine Pharmaceuticals to accelerate patient access across Europe
Today, Abacus Medicine Pharma Services is becoming Abacus Medicine Pharmaceuticals (AMP), a commercial-stage European pharmaceutical company.
Abacus Medicine to acquire Retail and Hospital division from A.forall
Complementary business profiles in Belgium provide strong commercial rationale.
Abacus Medicine Group appoints new Chief People Officer and new Chief Commercial Officer for Pharma Services
Eva Berner, new Chief People Officer, and Jörg Schulze, new Chief Commercial Officer for Abacus Medicine Pharma Services, are joining the Chief Executive Management Team.
Sustainability Report 2024: 20 years of care and contribution
In our Sustainability Report 2024, we demonstrate how we increasingly recognise the crucial link between ESG and business performance, highlighting our sustainability efforts the past year.
Abacus Medicine Group celebrates record year
In 2024, the Abacus Medicine Group celebrated 20 years of strong, organic growth. Revenue grew 23% to EUR 1,487 million, while EBITDA reached a record high of EUR 50.5 million and the Free cash flow was EUR 26.4 million.
The Abacus Medicine Group Today Announces the Nomination of Two New Members of The Board of Directors
Alette Verbeek and Sharon Curran are being nominated by the main shareholders, Wagner Family Holding ApS (approx. 58% ownership) and Chr. Augustinus Fabrikker Aktieselskab (approx. 35% ownership). All shareholders have been invited to an extraordinary general meeting on 4th October, 2024.
Our press releases are intended for the media
To comply with applicable regulation, product-related press releases are removed from our website within three weeks of publication. They are available upon request.
